IL-33 promotes colon cancer stemness. IL-33 treatment in vitro increased HT29 and primary human CRC cell expression of stem markers NANOG, NOTCH3, OCT3, OCT4 and Lgr5, and enhanced sphere formation. The gene discussed is IL33; the disease is colorectal carcinoma.